Skip to main content

Animations

MJFF Publications

1811 - 1820 of 8399 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • OPEN
    Title: Large-scale biophysically detailed model of somatosensory thalamocortical circuits in NetPyNE
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2022.884245
    Citation Count: 20
  • OPEN
    Title: Temporal order of clinical and biomarker changes in familial frontotemporal dementia
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-022-01942-9
    Citation Count: 87
  • OPEN
    Title: Concerns about the European Academy's Recommendations and Guidelines Regarding Pallidotomy for Parkinson's Disease
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/ene.15569
    Citation Count: 4
  • OPEN
    Title: Cumulative Effect of Head Injuries on Nonmotor Outcomes in Parkinson’s Disease
    Journal Name: The Journal of Neuropsychiatry and Clinical Neurosciences
    Publisher: American Psychiatric Association Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1176/appi.neuropsych.21100257
    Best OA location URL:
    Citation Count: 3
  • RESTRICTED
    Title: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669
    Best OA location URL:
    Citation Count: 53
  • OPEN
    Title: Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-32944-3
    Citation Count: 38
  • OPEN
    Title: Relationship of serum beta‐synuclein with blood biomarkers and brain atrophy
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.12790
    Citation Count: 27
  • RESTRICTED
    Title: Association of Total Bilirubin with Motor Signs in Early Parkinson’s Disease in LRRK2 Variant Carriers
    Journal Name: Journal of Molecular Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s12031-022-02067-x
    Best OA location URL:
    Citation Count: 0
  • OPEN
    Title: Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based Review
    Journal Name: Dystonia
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/dyst.2022.10655
    Citation Count: 6
  • OPEN
    Title: Interpretable deep learning of myelin histopathology in age-related cognitive impairment
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-022-01425-5
    Citation Count: 27
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.